BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19956908)

  • 1. TGF-beta superfamily enhances the antigen-induced IFN-gamma production by effector/memory CD8+ T cells.
    Takai S; Tokuda H; Matsushima-Nishiwaki R; Saio M; Takami T; Kozawa O
    Int J Mol Med; 2010 Jan; 25(1):105-11. PubMed ID: 19956908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S; Seelig M; Lee HM; Lin J
    J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
    Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
    Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
    Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
    Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
    Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta regulates pathology but not tissue CD8+ T cell dysfunction during experimental Trypanosoma cruzi infection.
    Martin DL; Postan M; Lucas P; Gress R; Tarleton RL
    Eur J Immunol; 2007 Oct; 37(10):2764-71. PubMed ID: 17823982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
    Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM
    Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
    Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
    Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta1 suppresses IFN-gamma-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation.
    Takaki H; Minoda Y; Koga K; Takaesu G; Yoshimura A; Kobayashi T
    Genes Cells; 2006 Aug; 11(8):871-82. PubMed ID: 16866871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.
    Hunter CA; Bermudez L; Beernink H; Waegell W; Remington JS
    Eur J Immunol; 1995 Apr; 25(4):994-1000. PubMed ID: 7737303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.
    Dumont FJ; Kastner CA
    J Cell Physiol; 1994 Jul; 160(1):141-53. PubMed ID: 8021294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
    Koehler H; Kofler D; Hombach A; Abken H
    Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CD8 T cell subsets.
    Erard F; Garcia-Sanz JA; Moriggl R; Wild MT
    J Immunol; 1999 Jan; 162(1):209-14. PubMed ID: 9886388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.
    Delvig AA; Lee JJ; Chrzanowska-Lightowlers ZM; Robinson JH
    J Leukoc Biol; 2002 Jul; 72(1):163-6. PubMed ID: 12101276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced antigen concentration and costimulatory blockade increase IFN-gamma secretion in naive CD8+ T cells.
    Hall HT; Petrovic J; Höglund P
    Eur J Immunol; 2004 Nov; 34(11):3091-101. PubMed ID: 15384046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
    Gunturi A; Berg RE; Crossley E; Murray S; Forman J
    Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
    Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
    Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.